Modification of Parkinsonism--chronic treatment with L-dopa

The New England Journal of Medicine
G C CotziasR Gellene

Abstract

No abstract listed.

References

Sep 1, 1967·The Journal of Pharmacy and Pharmacology·N E AndénT Hökfelt
Jan 1, 1967·International Review of Neurobiology·W P Koella, J Sutin
Mar 1, 1966·Brain : a Journal of Neurology·L J PoirierS Carabin
Feb 16, 1967·The New England Journal of Medicine·G C CotziasL M Schiffer
Jun 24, 1967·British Medical Journal
Oct 1, 1963·Circulation·A SJOERDSMAK ENGELMAN
Jan 1, 1965·British Medical Bulletin·T L SOKES

❮ Previous
Next ❯

Citations

Oct 1, 1972·Journal of Clinical Psychology·M B MaskinD Chabot
Aug 6, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·K A ReardonP A Kempster
Jun 1, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·R A HauserC W Olanow
Mar 1, 1978·Annals of Neurology·S G DiamondL J Treciokas
May 19, 1998·Annals of Neurology·S Fahn
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Julie A RobichaudDaniel M Corcos
Dec 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Craig D McCollPeter A Kempster
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·P KrackP Pollak
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·M J SteigerC D Marsden
Jul 1, 1993·Movement Disorders : Official Journal of the Movement Disorder Society·S A Factor, W J Weiner
Mar 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·T MendisJ D Grimes
Mar 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·W H Oertel, R C Dodel
Nov 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·M Nomoto, S Iwata
Jan 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·L J BornE M Quigley
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·A Albanese
Feb 26, 1973·Zeitschrift für Neurologie·S LavyS Feldman
Jan 1, 1972·Zeitschrift für Neurologie·C Fehling
Jan 1, 1971·Zeitschrift für Neurologie·J Chaco, O Abramsky
Jan 1, 1996·Dysphagia·N A Leopold, M C Kagel
Oct 15, 1975·Naunyn-Schmiedeberg's Archives of Pharmacology·W Kehr
Sep 1, 1971·European Journal of Clinical Pharmacology·B Johansson, B E Roos
Mar 1, 1978·The American Journal of Digestive Diseases·A L Hurwitz, A Duranceau
Jan 1, 1973·Journal of Neural Transmission·W BirkmayerP Riederer
Jan 1, 1978·Journal of Neural Transmission·U K RinneV Sonninen
Jan 1, 1972·Journal of Neural Transmission·W BirkmayerP Riederer
Nov 16, 1987·Klinische Wochenschrift·G HasenfussH Just
Jan 1, 1992·Psychopharmacology·R J Carey
Mar 1, 1971·Irish Journal of Medical Science·S F Murphy
Dec 20, 2007·European Journal of Clinical Pharmacology·Nick Holford, John G Nutt
Oct 14, 2005·Journal of Neurology·Stanley Fahn, UNKNOWN Parkinson Study Group
Mar 6, 2007·Journal of Neurology·Christian BlahakJoachim K Krauss
Nov 26, 2010·Journal of Neurology·Mario ZappiaWerner Poewe
Oct 3, 2001·Current Treatment Options in Neurology·Stewart A. Factor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

© 2022 Meta ULC. All rights reserved